TWIST1, A novel androgen-regulated gene, is a target for NKX3-1 in prostate cancer cells

Cancer Cell International

Volumn 13, Issue 1, 2013, Pages

  Eide, Turid ^a   Ramberg, Håkon ^a   Glackin, Carlotta ^c   Tindall, Donald ^d   Taskén, Kristin Austlid ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d DEPARTMENT OF UROLOGY   (United States)

Author keywords

LNCaP cells; NKX3 1; Prostate cancer; TWIST1

Indexed keywords

ANDROGEN; MESSENGER RNA; NKX3-1 PROTEIN; SMALL INTERFERING RNA; TUMOR SUPPRESSOR PROTEIN; TWIST1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL STRAIN LNCAP; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN BINDING; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; UPREGULATION;

EID: 84873035468     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-13-4     Document Type: Article

References (20)

1. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715. 10.1016/j.cell.2008.03.027, 2728032, 18485877.
2. Birchmeier W, Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1994, 1198:11-26.
3. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117:927-939. 10.1016/j.cell.2004.06.006, 15210113.
4. Alexander NR, Tran NL, Rekapally H, Summers CE, Glackin C, Heimark RL. N-cadherin gene expression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist1. Cancer Res 2006, 66:3365-3369. 10.1158/0008-5472.CAN-05-3401, 16585154.
5. Kwok WK, Ling MT, Lee TW, Lau TC, Zhou C, Zhang X, et al. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res 2005, 65:5153-5162. 10.1158/0008-5472.CAN-04-3785, 15958559.
6. Bethel CR, Faith D, Li X, Guan B, Hicks JL, Lan F, et al. Decreased NKX3.1 Protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion. Cancer Res 2006, 66:10683-10690. 10.1158/0008-5472.CAN-06-0963, 17108105.
7. Gelmann EP, Bowen C, Bubendorf L. Expression of NKX3.1 In normal and malignant tissues. Prostate 2003, 55:111-117. 10.1002/pros.10210, 12661036.
8. Bhatia-Gaur R, Donjacour AA, Sciavolino PJ, Kim M, Desai N, Young P, et al. Roles for Nkx3.1 In prostate development and cancer. Genes Dev 1999, 13:966-977. 10.1101/gad.13.8.966, 316645, 10215624.
9. Prescott JL, Blok L, Tindall DJ. Isolation and androgen regulation of the human homeobox cDNA, NKX3.1. Prostate 1998, 35:71-80. 10.1002/(SICI)1097-0045(19980401)35:1<71::AID-PROS10>3.0.CO;2-H, 9537602.
10. Shen MM, Wang X, Economides KD, Walker D, Abate-Shen C. Progenitor cells for the prostate epithelium: roles in development, regeneration, and cancer. Cold Spring Harb Symp Quant Biol 2008, 73:529-538. 10.1101/sqb.2008.73.050, 19150960.
11. Quandt K, Frech K, Karas H, Wingender E, Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 1995, 23:4878-4884. 10.1093/nar/23.23.4878, 307478, 8532532.
12. Takayama K, Tsutsumi S, Katayama S, Okayama T, Horie-Inoue K, Ikeda K, et al. Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells. Oncogene 2011, 30:619-630. 10.1038/onc.2010.436, 20890304.
13. Carson JA, Fillmore RA, Schwartz RJ, Zimmer WE. The smooth muscle gamma-actin gene promoter is a molecular target for the mouse bagpipe homologue, mNkx3-1, and serum response factor. J Biol Chem 2000, 275:39061-39072. 10.1074/jbc.M006532200, 10993896.
14. Simmons SO, Horowitz JM. Nkx3.1 Binds and negatively regulates the transcriptional activity of Sp-family members in prostate-derived cells. Biochem J 2006, 393:397-409. 10.1042/BJ20051030, 1383699, 16201967.
15. Abate-Shen C, Shen MM, Gelmann E. Integrating differentiation and cancer: the Nkx3.1 Homeobox gene in prostate organogenesis and carcinogenesis. Differentiation 2008, 76:717-727. 10.1111/j.1432-0436.2008.00292.x, 18557759.
16. Bowen C, Bubendorf L, Voeller HJ, Slack R, Willi N, Sauter G, et al. Loss of NKX3.1 Expression in human prostate cancers correlates with tumor progression. Cancer Res 2000, 60:6111-6115.
17. Song H, Zhang B, Watson MA, Humphrey PA, Lim H, Milbrandt J. Loss of Nkx3.1 Leads to the activation of discrete downstream target genes during prostate tumorigenesis. Oncogene 2009, 28:3307-3319. 10.1038/onc.2009.181, 2746257, 19597465.
18. Li J, Zhou BP. Activation of beta-catenin and Akt pathways by twist are critical for the maintenance of EMT associated cancer stem cell-like characters. BMC Cancer 2011, 11:49. 10.1186/1471-2407-11-49, 3040162, 21284870.
19. Kvissel AK, Ramberg H, Eide T, Svindland A, Skalhegg BS, Tasken KA. Androgen dependent regulation of protein kinase a subunits in prostate cancer cells. Cell Signal 2007, 19:401-409. 10.1016/j.cellsig.2006.07.011, 16949795.
20. Ramberg H, Eide T, Krobert KA, Levy FO, Dizeyi N, Bjartell AS, et al. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer. Prostate 2008, 68:1133-1142. 10.1002/pros.20778, 18454446.